Tocolytics for delaying preterm birth: a network meta‐analysis (0924)
A Wilson, VA Hodgetts-Morton… - Cochrane Database …, 2022 - cochranelibrary.com
Background Preterm birth is the leading cause of death in newborns and children. Tocolytic
drugs aim to delay preterm birth by suppressing uterine contractions to allow time for …
drugs aim to delay preterm birth by suppressing uterine contractions to allow time for …
Cyclo‐oxygenase (COX) inhibitors for treating preterm labour
HE Reinebrant, C Pileggi‐Castro… - Cochrane database …, 2015 - cochranelibrary.com
Background Preterm birth is a major cause of perinatal mortality and morbidity. Cyclo‐
oxygenase (COX) inhibitors inhibit uterine contractions, are easily administered and appear …
oxygenase (COX) inhibitors inhibit uterine contractions, are easily administered and appear …
[PDF][PDF] WHO recommendations on interventions to improve preterm birth outcomes
World Health Organization - 2015 - apps.who.int
Preterm babies are prone to serious illness or death during the neonatal period. Without
appropriate treatment, those who survive are at increased risk of lifelong disability and poor …
appropriate treatment, those who survive are at increased risk of lifelong disability and poor …
Preterm labor and birth management: recommendations from the European Association of Perinatal Medicine
GC Di Renzo, L Cabero Roura… - The Journal of …, 2017 - Taylor & Francis
GC Di Renzo a, L. Cabero Roura b, F. Facchinetti c, H. Helmer d, C. Hubinont e, B.
Jacobsson f, JS Jørgensen g, RF Lamont h, i, A. Mikhailov j, N. Papantoniou k, V. Radzinsky …
Jacobsson f, JS Jørgensen g, RF Lamont h, i, A. Mikhailov j, N. Papantoniou k, V. Radzinsky …
Combination of tocolytic agents for inhibiting preterm labour
JP Vogel, JM Nardin, T Dowswell… - Cochrane database …, 2014 - cochranelibrary.com
Background Preterm birth represents the single largest cause of mortality and morbidity for
newborns and a major cause of morbidity for pregnant women. Tocolytic agents include a …
newborns and a major cause of morbidity for pregnant women. Tocolytic agents include a …
Nifedipine versus atosiban for threatened preterm birth (APOSTEL III): a multicentre, randomised controlled trial
EOG Van Vliet, TAJ Nijman, E Schuit, KY Heida… - The Lancet, 2016 - thelancet.com
Background In women with threatened preterm birth, delay of delivery by 48 h allows
antenatal corticosteroids to improve neonatal outcomes. For this reason, tocolytics are often …
antenatal corticosteroids to improve neonatal outcomes. For this reason, tocolytics are often …
Landscape of preterm birth therapeutics and a path forward
BS Coler, O Shynlova, A Boros-Rausch, S Lye… - Journal of Clinical …, 2021 - mdpi.com
Preterm birth (PTB) remains the leading cause of infant morbidity and mortality. Despite 50
years of research, therapeutic options are limited and many lack clear efficacy. Tocolytic …
years of research, therapeutic options are limited and many lack clear efficacy. Tocolytic …
Preterm labor: a comprehensive review of guidelines on diagnosis, management, prediction and prevention
S Giouleka, I Tsakiridis, N Kostakis… - Obstetrical & …, 2022 - journals.lww.com
Preterm Labor: A Comprehensive Review of Guidelines on Diagn... : Obstetrical & Gynecological
Survey Preterm Labor: A Comprehensive Review of Guidelines on Diagnosis, Management …
Survey Preterm Labor: A Comprehensive Review of Guidelines on Diagnosis, Management …
An overview of systematic reviews of randomized-controlled trials for preventing necrotizing enterocolitis in preterm infants
Necrotizing enterocolitis (NEC) remains a major cause for neonatal mortality and morbidity
in preterm infants. The purpose of this review was to summarize evidence from systematic …
in preterm infants. The purpose of this review was to summarize evidence from systematic …
Surface-functionalized nanoparticles as efficient tools in targeted therapy of pregnancy complications
Minimizing exposure of the fetus to medication and reducing adverse off-target effects in the
mother are the primary challenges in developing novel drugs to treat pregnancy …
mother are the primary challenges in developing novel drugs to treat pregnancy …